Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
12/2008
12/17/2008EP2001999A1 Phytase variants
12/17/2008EP1536778B1 Proteins binding to cross-beta structure comprising amyloid and methods for modulation of the cross-beta structure, its formation and its associated toxicity
12/17/2008EP1352050B1 Microbiological method for producing amides
12/17/2008EP1189995B1 Enzymatic preservation of water based paints
12/17/2008EP1141232B1 Preservation of sensitive biologicial materials at ambient temperatures by vitrification
12/17/2008EP1012250B1 Regulation of gene expression in plants
12/17/2008EP0981626B1 Fungicidal test method
12/17/2008EP0909317B1 Compositions for modulating the length of telomeres
12/17/2008EP0791067B1 Protein kinase npk-110
12/17/2008CN101326283A 新型脂肪酶 The new lipase
12/17/2008CN101323858A Xylose isomerase, and encoding gene and use thereof
12/17/2008CN101323849A Preparation of liquid beta-diastase
12/17/2008CN101323848A Method for fermentation production of F.solani pisi cutinase by temperature two-stage control strategy
12/17/2008CN101323847A Cyclic maltosyl maltose, cyclic maltosyl maltose synthase, method of producing the same and use thereof
12/17/2008CN101323846A Three functional mutants of human phase II metabolic enzyme, construction and use thereof
12/17/2008CN101323845A Preparation of superoxide dismutase modified by lauroyl chloride
12/17/2008CN101322840A Human cystathionine beta-synthetase recombinant protein and use
12/17/2008CN100443589C Production of beta-amylase concentrated liquid with high conversion-rate and purity
12/16/2008US7467046 Designing a ligand for a farnesyl transferase; allows classification of putative protein prenyltransferase sequences and can facilitate optimization of GGTase-I and FTase modulators
12/16/2008US7465852 nucleotide molecules comprising sequences for thioredoxin h and NADPH-thioredoxin reductase; can be used to transform plants alone or in combination with other sequences to manipulate thioredoxin h system and alter protein disulfide status
12/16/2008US7465851 Expression vector comprising nucleotide sequences coding carbohydrate modifiying enzyme for use in enhancing quality of foodstuffs and baked goods
12/16/2008US7465850 by expressing a polypeptide from yeast that when expressed will increase the total amount of oil (i.e. triacylglycerols TAG) that is produced in transgenic organisms
12/16/2008US7465786 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders
12/16/2008US7465785 Polypeptide encoded by a nucleic acid over-expressed in melanoma
12/16/2008US7465577 disruption of the newly isolated P. pastoris AMR2 gene encoding beta 1,2-mannosyltransferase
12/16/2008US7465575 Metabolically engineered lactic acid bacteria and their use
12/16/2008US7465572 De-immunized streptokinase
12/16/2008US7465571 Endoglucanases
12/16/2008US7465570 Variant lipolytic enzymes
12/16/2008US7465569 Flavone synthases, methods of using flavone synthases, and plants expressing flavone synthases
12/16/2008US7465568 isolated nucleic acid molecule consisting of a polynucleotide sequence encoding polypeptides that have been shown to be essential for Candida albicans growth and survival; Fungal Conserved Genes ("FCG"), or Conserved Unknown Reading Frames ("CURFs")
12/16/2008US7465567 Polymorphic monooxygenase comprising mutation in heme domain of a secondary structural element and enhanced heat stability; improved peroxide-driven hydroxylation
12/16/2008US7465565 Using transgenic yarrowia as biorector for production of omega-3 or omega-6 fatty acids
12/16/2008US7465563 Enzymatic process for the manufacture of L-ascorbic acid and D-erythorbic acid
12/16/2008US7465557 Method of selecting barley variety, barley β-amylase gene and process for producing malt alcoholic drink
12/16/2008US7465539 Heat resistant polymerases for use as tools in genetic engineering; enzymatic extension of DNA strands
12/16/2008US7465464 Populations of cells that express flk-2 receptors
12/16/2008US7465452 Tumor antigen
12/16/2008US7465443 Acellular antibordetella vaccine
12/16/2008CA2268099C Screening methods for glucocorticoid receptor binding substances using tripterygium wilfordii preparations
12/16/2008CA2239692C Diagnosis and treatment of aur-1 and/or aur-2 related disorders
12/16/2008CA2177554C Reduction in first slide bias and improved enzyme stability by the incorporation of diaryl tellurides in thin-film immunoassay elements
12/16/2008CA2154581C Functional domains in flavobacterium okeanokoites (foki) restriction endonuclease
12/11/2008WO2008151043A1 Methods of increasing the cellulolytic enhancing activity of a polypeptide
12/11/2008WO2008150880A1 Process for starch liquefaction and fermentation
12/11/2008WO2008150509A1 Methods and compositions for treating spinal muscular atrophy
12/11/2008WO2008150376A1 Use of an aspartic protease (nsp24) signal sequence for heterologous protein expression
12/11/2008WO2008150101A2 Chimeric polypeptide including a mussel adheisve protein and extracellular matrix
12/11/2008WO2008149823A1 Novel thermostable dna polymerase
12/11/2008WO2008149176A1 Meganuclease variants cleaving a dna target sequence from the mouse rosa26 locus and uses thereof
12/11/2008WO2008148845A2 Method of preparing a dough-based product
12/11/2008WO2008148640A1 Microbiological production of aldehydes, especially of 3-hydroxypropionaldehyde
12/11/2008WO2008128161A3 Identification of cardiac specific myosin light chain kinase
12/11/2008WO2008100376A3 Truncation variants of sirt1 and methods of use thereof
12/11/2008WO2008070368A3 Methods and compositions for skin care
12/11/2008WO2008069958A3 Substrate switched ammonia lyases and mutases
12/11/2008WO2008006102A3 Use of retro-aldol reaction to generate reactive vinyl ketone for attachment to anitibody molecules by michael addition reaction for use in immunostaining and immunotargeting
12/11/2008WO2007102936A3 Polynucleotides for production of farnesyl dibenzodiazepinones
12/11/2008WO2007089690A3 Tat-042 and methods of assessing and treating cancer
12/11/2008US20080307547 Stimulating root growth via introducing cytokinin oxidase protein sequences; point mutations
12/11/2008US20080307543 Transcription Factor Stress-Related Proteins and Methods of Use in Plants
12/11/2008US20080306063 Phenylamino isothiazole carboxamidines as mek inhibitors
12/11/2008US20080306056 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
12/11/2008US20080306001 Transcriptional modulation of extracellular matrix (ecm) of dermal fibroblasts
12/11/2008US20080305991 Factor IX: remodeling and glycoconjugation of factor IX
12/11/2008US20080305535 In vitro amplification of nucleic acid molecules via circular replicons
12/11/2008US20080305534 Novel Glycerol Dehydrogenase, Gene Therefor, and Method of Utilizing the Same
12/11/2008US20080305529 Glucose Isomerase Mutants, Dna Thereof and Use Thereof
12/11/2008US20080305525 production system for a recombinant glycoprotein having therapeutic value in humans using a methylotrophic, thermotolerant yeast; host system for mass production of recombinant hepatitis vaccines
12/11/2008US20080305521 Method for Overproducing Specific Recombinant Protein with P. Cinnabarinus Monokaryotic Strains
12/11/2008US20080305518 O-Linked Glycoforms Of Polypeptides And Method To Manufacture Them
12/11/2008US20080305504 Compositions, methods, and kits for assaying complement activation
12/11/2008US20080305502 Method of Screening Baff Suppressor or Inhibitor
12/11/2008US20080305499 Anti-Synoviolin Antibody
12/11/2008US20080305496 Method for identifying a compound that modulates SIR2 protein activity
12/11/2008US20080305181 Compositions and Methods for Treatment of Vascular Grafts
12/11/2008US20080305106 Novel Gene Disruptions, Composition and Methods Relating Thereto
12/11/2008US20080305099 degrades soluble and insoluble A beta so that it can prevent the accumulation of A beta in brain or reduce the accumulation; Alzheimer's disease and Down's syndrome
12/11/2008US20080305098 Recombinant Polypeptides and Methods for Detecting and/or Quantifying Autoantibodies Against Tsh Receptor
12/11/2008US20080305091 Poly-Epitope Peptide Derived from Thymidylate Synthase Having Immunological and Anti-Tumour Activity
12/11/2008US20080305084 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions
12/11/2008US20080305044 Engineered Antibodies and Immunoconjugates
12/11/2008US20080305041 Pf4 Pharmacophores and Their Uses
12/11/2008US20080305038 Transport of Nano-and Macromolecular Structures Into Cytoplasm and Nucleus of Cells
12/11/2008US20080301882 Combining BioPolishing and Bleach Clean-up
12/11/2008CA2857507A1 Use of genetically modified organisms to generate biomass degrading enzymes
12/11/2008CA2689972A1 Method of preparing a dough-based product
12/11/2008CA2689910A1 Compositions for degrading cellulosic material
12/11/2008CA2689261A1 Methods of increasing the cellulolytic enhancing activity of a polypeptide
12/11/2008CA2688682A1 Cytochrome p450 genes conferring herbicide resistance
12/10/2008EP2000537A2 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
12/10/2008EP2000536A2 Tat-derived transport polypeptides
12/10/2008EP2000532A1 Methods of measuring human cytochrome P450 (CYP2C8/9)
12/10/2008EP1999267A2 Methods of expressing gam-negative glycosaminoglycosaminoglycan synthase genes in gram-positive hosts
12/10/2008EP1999264A2 Method for the enzymatic production of 2-hydroxy-2-methyl carboxylic acids
12/10/2008EP1999258A1 Novel aldolase and production process of 4-hydroxy-l-isoleucine
12/10/2008EP1999257A2 Polypeptides having endoglucanase activity and polynucleotides encoding same
12/10/2008EP1999256A2 Aldolases, nucleic acids encoding them and methods for making and using them
12/10/2008EP1999254A1 Beta-galactosidase with transgalactosylating activity
12/10/2008EP1758997B1 Episomal fusion gene